H
Houjie Liang
Researcher at Third Military Medical University
Publications - 21
Citations - 5206
Houjie Liang is an academic researcher from Third Military Medical University. The author has contributed to research in topics: Cancer research & Medicine. The author has an hindex of 6, co-authored 9 publications receiving 4468 citations. Previous affiliations of Houjie Liang include Zhejiang University.
Papers
More filters
Journal ArticleDOI
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.
Ann-Lii Cheng,Yoon-Koo Kang,Zhendong Chen,Chao Jung Tsao,Shukui Qin,Jun Suk Kim,Rongcheng Luo,Jifeng Feng,Sheng-Long Ye,Tsai Sheng Yang,Jianming Xu,Yan Sun,Houjie Liang,Jiwei Liu,Jiejun Wang,Won Young Tak,Hongming Pan,Karin Burock,Jessie Zou,D. Voliotis,Zhongzhen Guan +20 more
TL;DR: Sorafenib is effective for the treatment of advanced hepatocellular carcinoma in patients from the Asia-Pacific region, and is well tolerated.
Journal ArticleDOI
[Results of randomized, multicenter, double-blind phase III trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients].
Jinwan Wang,Yan Sun,Yong Yu Liu,Qitao Yu,Yiping Zhang,Kai Li,Yun-zhong Zhu,Qinghua Zhou,Mei Hou,Zhongzhen Guan,Weilian Li,Wu Zhuang,Donglin Wang,Houjie Liang,Fengzhan Qin,Huishan Lu,Xiaoqing Liu,Hong Sun,Yanjun Zhang,Jiejun Wang,Suxia Luo,Ruihe Yang,Yuanrong Tu,X. Wang,Shu-ping Song,Jingmin Zhou,Li-fen You,Jing Wang,Chen Yao +28 more
TL;DR: The addition of YH-16 to NP regimen results in significantly and clinically meaningful improvement in response rate, median time to tumor progression, and clinical benefit rate compared with NP alone in advanced NSCLC patients.
Journal ArticleDOI
Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition)
Jun Guo,Shukui Qin,Jun Liang,Tongyu Lin,Lu Si,Xiaohong Chen,Zhihong Chi,Chuanliang Cui,Nan Du,Yun Fan,Kangsheng Gu,Fang Li,Junling Li,Yongheng Li,Houjie Liang,Jiwei Liu,Man Lu,Aiping Lu,Kejun Nan,Xiaohui Niu,Hongming Pan,Guoxin Ren,Xiubao Ren,Yongqian Shu,Xin Song,Min Tao,Baocheng Wang,Wenbin Wei,Di Wu,L Y Wu,Aiwen Wu,Xiaolin Xu,Junyi Zhang,Xiaoshi Zhang,Yiping Zhang,Huiyan Zhu +35 more
TL;DR: The 2015 edition of the Chinese Guidelines on the Diagnosis and Treatment of Melanoma was finalized after repeated and wide consultations with multidisciplinary experts and updated and added with much new information, with an attempt to provide the up-todated and reliable instructions on clinical practices based recent scientific evidences.
Journal ArticleDOI
Interleukin‐17 Facilitates the Immune Suppressor Capacity of High‐Grade Glioma‐Derived CD4 (+) CD25 (+) Foxp3 (+) T Cells Via Releasing Transforming Growth Factor Beta
TL;DR: IL‐17+ Tregs exist in the high‐grade glioma tissue; this subset of T cells can suppress CD8+ T cell activities via releasing TGF‐beta and IL‐17.
Journal ArticleDOI
Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition).
Jun Guo,Shukui Qin,Jun Liang,Tongyu Lin,Lu Si,Xiaohong Chen,Zhihong Chi,Chuanliang Cui,Nan Du,Yun Fan,Kangsheng Gu,Fang Li,Junling Li,Yongheng Li,Houjie Liang,Jiwei Liu,Man Lu,Aiping Lu,Kejun Nan,Xiaohui Niu,Hongming Pan,Guoxin Ren,Xiubao Ren,Yongqian Shu,Xin Song,Min Tao,Baocheng Wang,Wenbin Wei,Di Wu,L Y Wu,Aiwen Wu,Xiaolin Xu,Junyi Zhang,Xiaoshi Zhang,Yiping Zhang,Huiyan Zhu +35 more
TL;DR: The 2015 edition of the Chinese Guidelines on the Diagnosis and Treatment of Melanoma was finalized after repeated and wide consultations with multidisciplinary experts and updated and added with much new information, with an attempt to provide the up-to-dated and reliable instructions on clinical practices based recent scientific evidences.